Open Your FREE Demat Account Now!

Colinz Laboratories Ltd. Share Price

NSE
BSE

BSE : 531210

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹67.50
Day's Range ₹67.50 - ₹69.50
Open ₹69.50
52 Week Range ₹36.58 - ₹87.91
Volume 67
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.05
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 6.11
TTM EPS (₹) 11.04
P/E Ratio 21.79
Book Value(₹) 1.34
PAT Margin (%) 8.38
Face Value (₹) 10.00
ROCE(%) 7.16

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 13.88 65.28
Expenses N/A N/A
PBT 1.86 6.2
Operating profit 0.0 0.0
Net profit 1.41 4.97

Shareholding Pattern

Promoters (% Holding)

50.60%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

49.40%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Colinz Laboratories Ltd.

Founded 1986

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,47,943.84 1,873.15 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,94,962.14 11,115.95 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,78,390.62 4,677.00 3,672.30 - 3,672.30
Lenskart Solutions Ltd. 1,27,829.39 752.05 0.00 - 0.00
Apollo Hospitals Enterprise Ltd. 1,25,900.72 8,792.60 6,696.50 - 6,696.50
Laurus Labs Ltd. 1,19,789.92 2,267.25 917.95 - 917.95
Zydus Lifesciences Ltd. 1,18,603.21 1,201.65 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,15,267.47 1,369.85 1,101.00 - 1,101.00
Cipla Ltd. 1,12,619.60 1,396.35 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,08,424.34 2,638.20 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Aug
20
2026
EQUITY Posted on Aug 20th 2026

Colinz Laboratories informs about book closure

Colinz Laboratories has informed that the 40thAGM of the Members of the Company is scheduled to be held on Tuesday the 22nd September, 2026, at 2.30 PM (IST) through Video Conferencing ('VC')/ Other Audio-Visual Means (‘OAVM’), as per the directive(s) of Ministry of Corporate Affairs and Securities and Exchange Board of India. As per section 108 of Companies Act,2013, read with Rule 20 of the Companies (Management and Administration) Rule, 2014 and all applicable provisions of the SEBI (LODR) Regulations, 2015, the Company is pleased to provide to its members the facility to cast their Vote(s) through remote e-voting starting from 19th September, 2026 (9.00 am) to 21st September, 2026 (5.00 pm), the cut-off date for remote e-voting is 15th September, 2026. E voting facility will also be available during AGM, to those members who did not exercise e voting during the above period. Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 91 of the Companies Act, 2013, the company has enclosed the details of Book Closure dates and calendar of events related to the 40th AGM of the Company.

The above information is a part of company’s filings submitted to BSE.  

Read More
Nov
16
2026
EQUITY Posted on Nov 16th 2026

Panacea Biotec informs about newspaper publication

In continuation to letter dated November 14, 2026, intimating approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, and pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Panacea Biotec has informed that it enclosed newspaper copies of the Extract of Statement of aforesaid Unaudited Financial Results published in the newspapers, Business Standard (English) and Desh Sewak (Punjabi) on November 16, 2026. 

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
16
2026
EQUITY Posted on Nov 16th 2026

Bafna Pharmaceuticals informs about press release

Bafna Pharmaceuticals has informed that it enclosed the Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter & Half Year ended September 30, 2026 as published in ‘Business Standard’ and 'Makkal Kural' on November 13, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
16
2026
EQUITY Posted on Nov 16th 2026

Nectar Lifesciences informs about press release

Nectar Lifesciences has informed that it enclosed a newspaper copy of Publication of Financial Results of the Company for the quarter and half year ended on September 30, 2026, which has been published in the following newspapers: Business Standard (English- all editions) dated 16.11.2026- circulating in the whole or substantially the whole of India; and Desh Sewak (Punjabi) dated 16.11.2026 being published in language of the region where the registered office of the Company is situated.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
16
2026
EQUITY Posted on Nov 16th 2026

Natural Capsules informs about disclosure

Natural Capsules has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Laxminarayana Mundra.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Colinz Laboratories Ltd. ?

The current share price of Colinz Laboratories Ltd. is ₹67.50 as of 2026-11-16.

The market capitalisation of Colinz Laboratories Ltd. is ₹17.00 as of 2026-11-16.

The 1-year return of Colinz Laboratories Ltd. is 24.76% as of 2026-11-16.

The P/E ratio of Colinz Laboratories Ltd. is 21.79 as of 2026-11-17.

The 52-week high and low of Colinz Laboratories Ltd. are ₹87.91 and ₹36.58, respectively, as of 2026-11-16.

The dividend yield of Colinz Laboratories Ltd. is 0.0% as of2026-11-16.

You can buy Colinz Laboratories Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Colinz Laboratories Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore